Press Releases
-
Certara Acquires Quantitative Systems Pharmacology Consultancy XenologiQ; Professor Piet van der Graaf to Lead New QSP Organization
PRINCETON, NJ - Dec 1, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that it has acquired XenologiQ, a UK-based quantitative systems pharmacology (QSP) consultancy
Dec 1, 2015
-
University of Edinburgh and Selcia Achieve Key Milestones in Bid to Develop New Drugs to Target Sleeping Sickness
ONGAR, UNITED KINGDOM - Nov 30, 2015 - Scientists from the University of Edinburgh, working with Selcia, an international life sciences contract research organisation, have successfully passed the 20-month milestone targets of a 30-month Wellcome Trust SDDi £2
Nov 30, 2015
-
Galen Healthcare Solutions Names Steve Brewer CEO
CHICAGO, IL, UNITED STATES - Nov 12, 2015 - Galen Healthcare Solutions Named to Modern Healthcare List of"Top Places to Work" for 3rd Consecutive Year Announces Steve Brewer as New CEO Galen Healthcare Solutions, a services and solutions company focusing on healthcare information technology, today announced that Steve Brewer has been named Chief Executive Officer
Nov 12, 2015
-
WIRB-Copernicus Group Launches Nonprofit WCG Foundation to Improve Global Clinical Research
PRINCETON, NJ - Nov 12, 2015 - WIRB-Copernicus Group® (WCG), the worlds largest provider of regulatory and ethical review services and software to support clinical research, today announced the launch of WCG Foundation
Nov 12, 2015
-
University of Chicago Graham School Launches Master of Science Degree in Biomedical Informatics
CHICAGO, IL, UNITED STATES - Nov 5, 2015 - Biomedical informatics, one of the worlds fastest-growing interdisciplinary fields, is the latest graduate degree program offered by the University of Chicago Graham School of Continuing Liberal and Professional Studies
Nov 5, 2015
-
ERT Achieves Record Third Quarter Results & Recognizes 40% Growth
PHILADELPHIA, PA, UNITED STATES - Nov 5, 2015 - ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced record bookings results throughout third quarter, 2015
Nov 5, 2015
-
Canbex Therapeutics Announces Start of Phase II Trial of VSN16R for Spasticity
LONDON, UNITED KINGDOM - Nov 2, 2015 - Canbex Therapeutics Ltd today announced that its novel orally active medication for the treatment of spasticity, VSN16R, has entered a Phase II trial in patients with spasticity caused by multiple sclerosis
Nov 2, 2015
-
FDA Equips its Pharmacometrics Teams with Certara’s Phoenix Software
PRINCETON, NJ - Nov 2, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that the United States Food and Drug Administration (FDA) has outfitted its pharmacometrics teams with Certaras Phoenix® software
Nov 1, 2015
-
ERT Scientists to Share COA / eCOA Expertise at ISPOR Annual European Congress
PHILADELPHIA, PA, UNITED STATES - Oct 29, 2015 - ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced that its scientific and regulatory experts will be featured presenters at the International Society for Pharmacoeconomics Research (ISPOR) Annual European Congress, November 7-11, 2015 in Milan, Italy
Oct 29, 2015
-
ERT Study Finds Patient Care and Clinical Trial Inclusion Rates May Benefit from Use of Centralized ECG Measurements
PHILADELPHIA, PA, UNITED STATES - Oct 26, 2015 - ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced the findings of a study that may have important implicationsfor subject recruitment and medication dosing in clinical oncology trials
Oct 26, 2015
-
ERT Insights Cloud™ Clinical Trials Intelligence Solution is Reshaping Traditional CTMS Functionality
PHILADELPHIA, PA, UNITED STATES - Oct 22, 2015 - ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions, today announced that Accelovance, a Contract Research Organization (CRO) focusing in oncology, vaccines, and general medicine, has selected ERTs Insights Cloud to replace the functionality of a traditional Clinical Trial Management System (CTMS)
Oct 22, 2015
-
Cenduit to Lead Panel at 2015 Interactive Response Technologies in Clinical Trials Forum in Philadelphia
RALEIGH, NC, UNITED STATES - Oct 20, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world by leading a panel at CBIs 2015 Interactive Response Technologies in Clinical Trials Forum
Oct 20, 2015
-
Japan’s Agency for Medical Research and Development, AMED, Selects Certara’s Phoenix WinNonlin Software to Assess New Drug Candidates
PRINCETON, NJ - Oct 20, 2015 - Certara®, the global biosimulation technology-enabled drug development company, today announced that Japans new Agency for Medical Research and Development (AMED) has selected Certaras Phoenix® WinNonlin® software for pharmacokinetic/pharmacodynamic (PK/PD) modeling and non-compartmental analysis of new drug candidates
Oct 20, 2015
-
ERT to Offer Demonstrations of Innovation Lab Prototypes
PHILADELPHIA, PA, UNITED STATES - Oct 19, 2015 - ERT, the leading cloud platform solutions provider delivering clinical and scientific innovation through its patient-centric data collection and intelligence solutions today announced that several prototypes from its Innovation Lab are now available for public demonstrations
Oct 19, 2015
-
ERT Announces Final Agenda, Faculty for U.S. PRO / eCOA Congress
PHILADELPHIA, PA, UNITED STATES - Oct 15, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the complete faculty and agenda of its 8th Annual U
Oct 15, 2015
-
Certara Joins EU-ToxRisk – An Integrated European ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century
PRINCETON, NJ - Oct 12, 2015 - An international consortium of 39 partner organizations will be funded by the European Commission to work on the integration of new concepts for regulatory chemical safety assessment
Oct 12, 2015
-
City of Hope Turns to PFS Clinical to Mitigate Regulatory and Financial Risk with Clinical Research Coverage Analysis and Budget Standardization
MIDDLETON, WI - Oct 7, 2015 - PFS Clinical, which offers turnkey administrative solutions that address the key pain points of establishing and running a clinical trial office, has been engaged by City of Hope to provide Coverage Analysis (CA) to ensure its clinical research trials remain compliant with complex Medicare billing regulations
Oct 7, 2015
-
Rho Clinical Research Expert to Exhibit at 2015 Annual North American Cystic Fibrosis Conference
CHAPEL HILL, NC, UNITED STATES - Oct 6, 2015 - WHAT: Rho, a full-service contract research organization (CRO), will exhibit at the 2015 North American Cystic Fibrosis Conference (NACFC), taking place on October 8-10, 2015 in Phoenix, Arizona
Oct 6, 2015
-
ERT Announces October Educational Events
PHILADELPHIA, PA, UNITED STATES - Oct 1, 2015 - ERT, a leading global provider of high-quality patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions today announced the educational events it is delivering during October for pharmaceutical researchers
Oct 1, 2015
-
Rho Donates $28,000 to Local Public Schools through DonorsChoose.org
CHAPEL HILL, NC, UNITED STATES - Oct 1, 2015 - Rho, a Chapel Hill-based contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the company will continue its support of public education in its home state through a $28,000 donation to high-poverty schools in the Research Triangle Park region of North Carolina
Oct 1, 2015
